Gene Synthesis Companies to Develop Biothreat Protocols | GenomeWeb

NEW YORK (GenomeWeb News) – Five international synthetic genetics companies have started a consortium that will focus on developing best practices for biosecurity protocols.

The International Gene Synthesis Consortium (IGSC), made up of Blue Heron Biotechnology, DNA2.0, GeneArt, GenScript and Integrated DNA Technologies, said today that it will work with governments and other interested parties to support efforts to keep gene synthesis technologies from being misused.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.